Blood Glucose Monitoring System-EMEA Market Status and Trend Report 2013-2023
Report Summary
Blood Glucose Monitoring System-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Blood Glucose Monitoring System industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Blood Glucose Monitoring System 2013-2017, and development forecast 2018-2023
Main market players of Blood Glucose Monitoring System in EMEA, with company and product introduction, position in the Blood Glucose Monitoring System market
Market status and development trend of Blood Glucose Monitoring System by types and applications
Cost and profit status of Blood Glucose Monitoring System, and marketing status
Market growth drivers and challenges
The report segments the EMEA Blood Glucose Monitoring System market as:
EMEA Blood Glucose Monitoring System Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Blood Glucose Monitoring System Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Self-Monitoring
Continuous Glucose Monitoring Devices
EMEA Blood Glucose Monitoring System Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinic
Homecare
Other
EMEA Blood Glucose Monitoring System Market: Players Segment Analysis (Company and Product introduction, Blood Glucose Monitoring System Sales Volume, Revenue, Price and Gross Margin):
Roche (Switzerland)
Abbott (US)
LifeScan (US)
Ascensia (Switzerland)
Medtronic (Ireland)
Dexcom (US)
Ypsomed (Switzerland)
B. Braun (Germany)
Nipro (Japan)
Sanofi (France)
ARKRAY (Japan)
Prodigy Diabetes Care (US)
ACON Laboratories (US)
Nova Biomedical (US)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Blood Glucose Monitoring System-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Blood Glucose Monitoring System industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Blood Glucose Monitoring System 2013-2017, and development forecast 2018-2023
Main market players of Blood Glucose Monitoring System in EMEA, with company and product introduction, position in the Blood Glucose Monitoring System market
Market status and development trend of Blood Glucose Monitoring System by types and applications
Cost and profit status of Blood Glucose Monitoring System, and marketing status
Market growth drivers and challenges
The report segments the EMEA Blood Glucose Monitoring System market as:
EMEA Blood Glucose Monitoring System Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Blood Glucose Monitoring System Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Self-Monitoring
Continuous Glucose Monitoring Devices
EMEA Blood Glucose Monitoring System Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinic
Homecare
Other
EMEA Blood Glucose Monitoring System Market: Players Segment Analysis (Company and Product introduction, Blood Glucose Monitoring System Sales Volume, Revenue, Price and Gross Margin):
Roche (Switzerland)
Abbott (US)
LifeScan (US)
Ascensia (Switzerland)
Medtronic (Ireland)
Dexcom (US)
Ypsomed (Switzerland)
B. Braun (Germany)
Nipro (Japan)
Sanofi (France)
ARKRAY (Japan)
Prodigy Diabetes Care (US)
ACON Laboratories (US)
Nova Biomedical (US)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF BLOOD GLUCOSE MONITORING SYSTEM
1.1 Definition of Blood Glucose Monitoring System in This Report
1.2 Commercial Types of Blood Glucose Monitoring System
1.2.1 Self-Monitoring
1.2.2 Continuous Glucose Monitoring Devices
1.3 Downstream Application of Blood Glucose Monitoring System
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Homecare
1.3.4 Other
1.4 Development History of Blood Glucose Monitoring System
1.5 Market Status and Trend of Blood Glucose Monitoring System 2013-2023
1.5.1 EMEA Blood Glucose Monitoring System Market Status and Trend 2013-2023
1.5.2 Regional Blood Glucose Monitoring System Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Blood Glucose Monitoring System in EMEA 2013-2017
2.2 Consumption Market of Blood Glucose Monitoring System in EMEA by Regions
2.2.1 Consumption Volume of Blood Glucose Monitoring System in EMEA by Regions
2.2.2 Revenue of Blood Glucose Monitoring System in EMEA by Regions
2.3 Market Analysis of Blood Glucose Monitoring System in EMEA by Regions
2.3.1 Market Analysis of Blood Glucose Monitoring System in Europe 2013-2017
2.3.2 Market Analysis of Blood Glucose Monitoring System in Middle East 2013-2017
2.3.3 Market Analysis of Blood Glucose Monitoring System in Africa 2013-2017
2.4 Market Development Forecast of Blood Glucose Monitoring System in EMEA 2018-2023
2.4.1 Market Development Forecast of Blood Glucose Monitoring System in EMEA 2018-2023
2.4.2 Market Development Forecast of Blood Glucose Monitoring System by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Blood Glucose Monitoring System in EMEA by Types
3.1.2 Revenue of Blood Glucose Monitoring System in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Blood Glucose Monitoring System in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Blood Glucose Monitoring System in EMEA by Downstream Industry
4.2 Demand Volume of Blood Glucose Monitoring System by Downstream Industry in Major Countries
4.2.1 Demand Volume of Blood Glucose Monitoring System by Downstream Industry in Europe
4.2.2 Demand Volume of Blood Glucose Monitoring System by Downstream Industry in Middle East
4.2.3 Demand Volume of Blood Glucose Monitoring System by Downstream Industry in Africa
4.3 Market Forecast of Blood Glucose Monitoring System in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BLOOD GLUCOSE MONITORING SYSTEM
5.1 EMEA Economy Situation and Trend Overview
5.2 Blood Glucose Monitoring System Downstream Industry Situation and Trend Overview
CHAPTER 6 BLOOD GLUCOSE MONITORING SYSTEM MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Blood Glucose Monitoring System in EMEA by Major Players
6.2 Revenue of Blood Glucose Monitoring System in EMEA by Major Players
6.3 Basic Information of Blood Glucose Monitoring System by Major Players
6.3.1 Headquarters Location and Established Time of Blood Glucose Monitoring System Major Players
6.3.2 Employees and Revenue Level of Blood Glucose Monitoring System Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BLOOD GLUCOSE MONITORING SYSTEM MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Roche (Switzerland)
7.1.1 Company profile
7.1.2 Representative Blood Glucose Monitoring System Product
7.1.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of Roche (Switzerland)
7.2 Abbott (US)
7.2.1 Company profile
7.2.2 Representative Blood Glucose Monitoring System Product
7.2.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of Abbott (US)
7.3 LifeScan (US)
7.3.1 Company profile
7.3.2 Representative Blood Glucose Monitoring System Product
7.3.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of LifeScan (US)
7.4 Ascensia (Switzerland)
7.4.1 Company profile
7.4.2 Representative Blood Glucose Monitoring System Product
7.4.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of Ascensia (Switzerland)
7.5 Medtronic (Ireland)
7.5.1 Company profile
7.5.2 Representative Blood Glucose Monitoring System Product
7.5.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of Medtronic (Ireland)
7.6 Dexcom (US)
7.6.1 Company profile
7.6.2 Representative Blood Glucose Monitoring System Product
7.6.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of Dexcom (US)
7.7 Ypsomed (Switzerland)
7.7.1 Company profile
7.7.2 Representative Blood Glucose Monitoring System Product
7.7.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of Ypsomed (Switzerland)
7.8 B. Braun (Germany)
7.8.1 Company profile
7.8.2 Representative Blood Glucose Monitoring System Product
7.8.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of B. Braun (Germany)
7.9 Nipro (Japan)
7.9.1 Company profile
7.9.2 Representative Blood Glucose Monitoring System Product
7.9.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of Nipro (Japan)
7.10 Sanofi (France)
7.10.1 Company profile
7.10.2 Representative Blood Glucose Monitoring System Product
7.10.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of Sanofi (France)
7.11 ARKRAY (Japan)
7.11.1 Company profile
7.11.2 Representative Blood Glucose Monitoring System Product
7.11.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of ARKRAY (Japan)
7.12 Prodigy Diabetes Care (US)
7.12.1 Company profile
7.12.2 Representative Blood Glucose Monitoring System Product
7.12.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of Prodigy Diabetes Care (US)
7.13 ACON Laboratories (US)
7.13.1 Company profile
7.13.2 Representative Blood Glucose Monitoring System Product
7.13.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of ACON Laboratories (US)
7.14 Nova Biomedical (US)
7.14.1 Company profile
7.14.2 Representative Blood Glucose Monitoring System Product
7.14.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of Nova Biomedical (US)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BLOOD GLUCOSE MONITORING SYSTEM
8.1 Industry Chain of Blood Glucose Monitoring System
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BLOOD GLUCOSE MONITORING SYSTEM
9.1 Cost Structure Analysis of Blood Glucose Monitoring System
9.2 Raw Materials Cost Analysis of Blood Glucose Monitoring System
9.3 Labor Cost Analysis of Blood Glucose Monitoring System
9.4 Manufacturing Expenses Analysis of Blood Glucose Monitoring System
CHAPTER 10 MARKETING STATUS ANALYSIS OF BLOOD GLUCOSE MONITORING SYSTEM
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Blood Glucose Monitoring System in This Report
1.2 Commercial Types of Blood Glucose Monitoring System
1.2.1 Self-Monitoring
1.2.2 Continuous Glucose Monitoring Devices
1.3 Downstream Application of Blood Glucose Monitoring System
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Homecare
1.3.4 Other
1.4 Development History of Blood Glucose Monitoring System
1.5 Market Status and Trend of Blood Glucose Monitoring System 2013-2023
1.5.1 EMEA Blood Glucose Monitoring System Market Status and Trend 2013-2023
1.5.2 Regional Blood Glucose Monitoring System Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Blood Glucose Monitoring System in EMEA 2013-2017
2.2 Consumption Market of Blood Glucose Monitoring System in EMEA by Regions
2.2.1 Consumption Volume of Blood Glucose Monitoring System in EMEA by Regions
2.2.2 Revenue of Blood Glucose Monitoring System in EMEA by Regions
2.3 Market Analysis of Blood Glucose Monitoring System in EMEA by Regions
2.3.1 Market Analysis of Blood Glucose Monitoring System in Europe 2013-2017
2.3.2 Market Analysis of Blood Glucose Monitoring System in Middle East 2013-2017
2.3.3 Market Analysis of Blood Glucose Monitoring System in Africa 2013-2017
2.4 Market Development Forecast of Blood Glucose Monitoring System in EMEA 2018-2023
2.4.1 Market Development Forecast of Blood Glucose Monitoring System in EMEA 2018-2023
2.4.2 Market Development Forecast of Blood Glucose Monitoring System by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Blood Glucose Monitoring System in EMEA by Types
3.1.2 Revenue of Blood Glucose Monitoring System in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Blood Glucose Monitoring System in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Blood Glucose Monitoring System in EMEA by Downstream Industry
4.2 Demand Volume of Blood Glucose Monitoring System by Downstream Industry in Major Countries
4.2.1 Demand Volume of Blood Glucose Monitoring System by Downstream Industry in Europe
4.2.2 Demand Volume of Blood Glucose Monitoring System by Downstream Industry in Middle East
4.2.3 Demand Volume of Blood Glucose Monitoring System by Downstream Industry in Africa
4.3 Market Forecast of Blood Glucose Monitoring System in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BLOOD GLUCOSE MONITORING SYSTEM
5.1 EMEA Economy Situation and Trend Overview
5.2 Blood Glucose Monitoring System Downstream Industry Situation and Trend Overview
CHAPTER 6 BLOOD GLUCOSE MONITORING SYSTEM MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Blood Glucose Monitoring System in EMEA by Major Players
6.2 Revenue of Blood Glucose Monitoring System in EMEA by Major Players
6.3 Basic Information of Blood Glucose Monitoring System by Major Players
6.3.1 Headquarters Location and Established Time of Blood Glucose Monitoring System Major Players
6.3.2 Employees and Revenue Level of Blood Glucose Monitoring System Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BLOOD GLUCOSE MONITORING SYSTEM MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Roche (Switzerland)
7.1.1 Company profile
7.1.2 Representative Blood Glucose Monitoring System Product
7.1.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of Roche (Switzerland)
7.2 Abbott (US)
7.2.1 Company profile
7.2.2 Representative Blood Glucose Monitoring System Product
7.2.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of Abbott (US)
7.3 LifeScan (US)
7.3.1 Company profile
7.3.2 Representative Blood Glucose Monitoring System Product
7.3.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of LifeScan (US)
7.4 Ascensia (Switzerland)
7.4.1 Company profile
7.4.2 Representative Blood Glucose Monitoring System Product
7.4.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of Ascensia (Switzerland)
7.5 Medtronic (Ireland)
7.5.1 Company profile
7.5.2 Representative Blood Glucose Monitoring System Product
7.5.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of Medtronic (Ireland)
7.6 Dexcom (US)
7.6.1 Company profile
7.6.2 Representative Blood Glucose Monitoring System Product
7.6.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of Dexcom (US)
7.7 Ypsomed (Switzerland)
7.7.1 Company profile
7.7.2 Representative Blood Glucose Monitoring System Product
7.7.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of Ypsomed (Switzerland)
7.8 B. Braun (Germany)
7.8.1 Company profile
7.8.2 Representative Blood Glucose Monitoring System Product
7.8.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of B. Braun (Germany)
7.9 Nipro (Japan)
7.9.1 Company profile
7.9.2 Representative Blood Glucose Monitoring System Product
7.9.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of Nipro (Japan)
7.10 Sanofi (France)
7.10.1 Company profile
7.10.2 Representative Blood Glucose Monitoring System Product
7.10.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of Sanofi (France)
7.11 ARKRAY (Japan)
7.11.1 Company profile
7.11.2 Representative Blood Glucose Monitoring System Product
7.11.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of ARKRAY (Japan)
7.12 Prodigy Diabetes Care (US)
7.12.1 Company profile
7.12.2 Representative Blood Glucose Monitoring System Product
7.12.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of Prodigy Diabetes Care (US)
7.13 ACON Laboratories (US)
7.13.1 Company profile
7.13.2 Representative Blood Glucose Monitoring System Product
7.13.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of ACON Laboratories (US)
7.14 Nova Biomedical (US)
7.14.1 Company profile
7.14.2 Representative Blood Glucose Monitoring System Product
7.14.3 Blood Glucose Monitoring System Sales, Revenue, Price and Gross Margin of Nova Biomedical (US)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BLOOD GLUCOSE MONITORING SYSTEM
8.1 Industry Chain of Blood Glucose Monitoring System
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BLOOD GLUCOSE MONITORING SYSTEM
9.1 Cost Structure Analysis of Blood Glucose Monitoring System
9.2 Raw Materials Cost Analysis of Blood Glucose Monitoring System
9.3 Labor Cost Analysis of Blood Glucose Monitoring System
9.4 Manufacturing Expenses Analysis of Blood Glucose Monitoring System
CHAPTER 10 MARKETING STATUS ANALYSIS OF BLOOD GLUCOSE MONITORING SYSTEM
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
